ACORDA THERAPEUTICS INC's ticker is ACOR and the CUSIP is 00484M106. A total of 185 filers reported holding ACORDA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $75,000 | +188.5% | 26,318 | +651.9% | 0.01% | +133.3% |
| Q2 2019 | $26,000 | -84.7% | 3,500 | -59.6% | 0.00% | -75.0% |
| Q3 2018 | $170,000 | +385.7% | 8,664 | +482.6% | 0.01% | +300.0% |
| Q3 2017 | $35,000 | -75.4% | 1,487 | -78.1% | 0.00% | -80.0% |
| Q1 2017 | $142,000 | -48.2% | 6,778 | -53.6% | 0.02% | -50.0% |
| Q4 2016 | $274,000 | -19.4% | 14,604 | -10.5% | 0.03% | -21.1% |
| Q3 2016 | $340,000 | -13.9% | 16,315 | +5.3% | 0.04% | -9.5% |
| Q2 2016 | $395,000 | +262.4% | 15,494 | +503.1% | 0.04% | +121.1% |
| Q4 2015 | $109,000 | +626.7% | 2,569 | +328.2% | 0.02% | +533.3% |
| Q3 2015 | $15,000 | -61.5% | 600 | -50.0% | 0.00% | -70.0% |
| Q1 2015 | $39,000 | -86.9% | 1,200 | -86.4% | 0.01% | -75.6% |
| Q3 2014 | $298,000 | +76.3% | 8,802 | +51.8% | 0.04% | -50.6% |
| Q4 2013 | $169,000 | +525.9% | 5,800 | +625.0% | 0.08% | +388.2% |
| Q3 2013 | $27,000 | – | 800 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 325,000 | $8,289,000 | 2.39% |
| ARMISTICE CAPITAL, LLC | 232,000 | $5,917,000 | 2.25% |
| SENZAR ASSET MANAGEMENT, LLC | 358,191 | $9,135,662,000 | 1.99% |
| SCOPIA CAPITAL MANAGEMENT LP | 3,171,229 | $80,882,000 | 1.67% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,029,410 | $26,255,000 | 1.03% |
| Baker Brothers Advisors | 3,661,082 | $93,376,000 | 0.98% |
| ARBOR CAPITAL MANAGEMENT LLC | 58,783 | $1,499,000 | 0.79% |
| Spark Investment Management LLC | 292,400 | $7,457,000 | 0.70% |
| SPHERA FUNDS MANAGEMENT LTD. | 98,000 | $2,499,000 | 0.65% |
| Virtus ETF Advisers LLC | 21,130 | $539,000 | 0.40% |